SAN DIEGO, Sept. 3, 2013 /PRNewswire/ -- ResMed, an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, today announced a new nasal mask, the Swift™ FX Nano, for use with positive airway pressure (PAP) therapy. This mask, available now throughout the U.S., represents a significant breakthrough for the nasal mask category.
"By combining the headgear design of a nasal pillows mask with the superior seal of a nasal mask we have created something for patients who want an effective mask that takes up less space," said Jon Yerbury, ResMed's vice president, Sleep-Disordered Breathing.
Swift FX Nano Nasal Mask – Combines the Best of Nasal Mask and Pillows
ResMed's Swift FX Nano nasal mask has a new proprietary design that keeps the mask small and unobtrusive without the need for rigid frames or forehead support. The result is a mask that more closely resembles a nasal pillows mask but carries the superior seal and performance of a nasal mask.
Easy to fit, wear and maintain, the Swift FX Nano nasal mask includes features to encourage compliance:
- Set-it-and-forget-it headgear that makes fitting the mask easy because there are only two points of adjustment, and "lock and key" assembly for swift attaching and detaching of the headgear
- Modified dual-wall cushion with trampoline action that provides a stable, comfortable seal
- Ultra-smooth ball joint where the air tube connects to the mask, allows the tube to move freely in virtually every direction
- Whisper-quiet venting that gently distributes air away from the patient and bed partner
- For Her option with headgear and cushion sizes designed for women
"There's a reason nasal masks are growing in popularity, and that's because they're comfortable and convenient," said Yerbury. "The Swift FX Nano goes one step further by being ultra-compact in size with minimal headgear and great performance."
Like all ResMed masks, the Swift FX Nano is ultra-soft and latex-free.
ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com. Related medicine technology :1
. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets2
. US Intranasal Drug Delivery Industry3
. Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landsc4
. Emerging Data on USL261 (Intranasal Midazolam) to Be Presented at the 66th Annual Meeting of the American Epilepsy Society5
. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone6
. Aegis Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment7
. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy8
. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 209
. Considering Corticosteroid Nasal Sprays10
. "AWAKEN" Survey Finds Only 50 Percent of Americans Understand Significant Health Impact of Narcolepsy, and Many Physicians Not Comfortable Diagnosing the Sleep Disorder11
. New Therapy Device Improves Patient Comfort as They Recover From Shoulder Injuries